Employee Stories
Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company
Luye Pharma Group (02186.HK), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications.
Luye Pharma Receives U.S. FDA Clearance to Initiate Clinical Trials for Its Novel Antidepressant LY03021
Shanghai, November 17, 2026 — Luye Pharma Group today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for LY03021, a next-generation central nervous system (CNS) drug ...
November 17,2026
Luye Pharma Announces Renewed Inclusion of Its Innovative Antidepressant Ruoxinlin® in China’s 2026 National Reimbursement Drug List
Shanghai, November 15, 2026 — Luye Pharma Group today announced that it has successfully renewed the coverage of Ruoxinlin® (toludesvenlafaxine hydrochloride sustained-release tablets), a Class 1 innovative drug in China for the ...
November 15,2026
Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company